Publications by authors named "JF Dillon"

Claim this Profile
E
Estimating incidence rates of primary infection and reinfection with hepatitis C virus among people who inject drugs in Scotland: a model-based analysis of repeated cross-sectional survey data.
Scott A McDonald, Norah Palmateer, Andrew McAuley, Rory N Gunson, Stephen T Barclay, John F Dillon

Lancet Reg Health Eur· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing the utility of a novel score for "At-Risk" MASH in those with significant obesity.
John F Dillon, Damien Leith, Paul Brennan

Hepatology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa-An Analysis of Systematic Review Data.
Getahun Molla Kassa, Aaron G Lim, Melaku Tileku Tamiru, Tesfa Sewunet Alamneh, Peter Vickerman, John F Dillon

J Viral Hepat· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons learned from two multicentre randomised controlled trials undertaken in pharmacies in community settings: a retrospective project management analysis.
Christopher J Byrne, Sarah K Inglis, Andrew Radley, Lewis J Beer, Minh D Pham, John F Dillon

Trials· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-treatment life-trajectories among people who inject drugs who completed hepatitis C treatment with direct acting antivirals: A thematic analysis.
Gabriele Vojt, Lawrie Elliott, Hannah Family, Christian Sharkey, Brian Stephens, John F Dillon

Br J Health Psychol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatology.
Dana Ivancovsky Wajcman, Aina Nicolàs, Camila A Picchio, Lena van Selm, Geoffrey Dusheiko, John F Dillon

JHEP Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisense oligonucleotide-directed liver therapy: a new tool in the MASH armamentarium?
Paul N Brennan, John F Dillon

Lancet· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A protocol for the evaluation of the PneumoWave biosensor in supported accommodation settings: A study on feasibility and acceptability (RESCU-2).
Basak Tas, Lewis Beer, Elizabeth Appiah-Kusi, Will Lawn, Iona Belov, John F Dillon

PLoS One· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of Non-Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review.
Jennifer Cathcart, Rachael Barrett, James S Bowness, Ashis Mukhopadhya, Ruairi Lynch, John F Dillon

Liver Int· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Treating Hepatitis C in Clients on Opioid Agonist Therapy in Community Pharmacies Compared to Primary Healthcare in Australia.
Joshua F Ginnane, Nick Scott, Andrew Radley, John F Dillon, Margaret Hellard

J Viral Hepat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroprevalence of Hepatitis C in Ethiopia: First National Study Based on the 2016 Ethiopian Demographic and Health Survey.
Getahun Molla Kassa, Atsbeha Gebreegziabxier Weldemariam, Saro Abdella Abrahim, Clare E French, Dawit Wolday, John F Dillon

J Viral Hepat· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.
Paul N Brennan, Mark MacMillan, Thomas Manship, Francesca Moroni, Alison Glover, John F Dillon

Nat Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future destinations: how people cured of hepatitis C using direct acting antiviral drugs progress in a new HCV-free world. A thematic analysis.
Sarah R Donaldson, Andrew Radley, John F Dillon

Harm Reduct J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, trends, and distribution of hepatitis C virus among the general population in sub-Saharan Africa: A systematic review and meta-analysis.
Getahun Molla Kassa, Josephine G Walker, Tesfa Sewunet Alamneh, Melaku Tileku Tamiru, Sandra Bivegete, John F Dillon

Liver Int· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver disease.
Dana Ivancovsky Wajcman, Christopher J Byrne, John F Dillon, Paul N Brennan, Marcela Villota-Rivas

Hepatology· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statement.
C Cook, L Reid, A M Elsharkawy, A Radley, S Smith, J F Dillon

Public Health· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice.
Paul N Brennan, Oliver D Tavabie, Wenhao Li, Thomas Marjot, Lynsey Corless, John F Dillon

Lancet Gastroenterol Hepatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced liver fibrosis (ELF) score predicts hepatic decompensation and mortality.
Madeline Pearson, Jennifer Nobes, Iain Macpherson, Lucy Gold, Michael Miller, John F Dillon

JHEP Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intelligent Liver Function Testing (iLFT): An Intelligent Laboratory Approach to Identifying Chronic Liver Disease.
Jennifer Nobes, Damien Leith, Sava Handjiev, John F Dillon, Ellie Dow

Diagnostics (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis.
Marc Gurun, Paul Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F Dillon

PLoS One· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFT.
Jeremy Lee, Christopher J Byrne, Paul N Brennan, Iain MacPherson, Eleanor Dow, John F Dillon

Ann Hepatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral hepatitis testing and treatment in community pharmacies: a systematic review and meta-analysis.
Mark J Hayes, Emma Beavon, Michael W Traeger, John F Dillon, Andrew Radley

EClinicalMedicine· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study.
Christopher J Byrne, Paul Brennan, James Carberry, James Cotton, John F Dillon

BMJ Open Gastroenterol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a liver health check in people with type 2 diabetes.
Kushala W M Abeysekera, Luca Valenti, Zobair Younossi, John F Dillon, Alina M Allen

Lancet Gastroenterol Hepatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid atrial pacing above the maximum sensor rate: a case report.
George M Bodziock, Patrick M Kozak, Carrie Pruitt, John F Dillon, Prashant D Bhave

Eur Heart J Case Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis